Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation

References

• Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;22(1):21. doi:10.3390/ijms22010021
   PubMedGoogle Scholar
• Ajlouni K, Khader Y, Alyousfi M, Al Nsour M, Batieha A, Jaddou H. Metabolic syndrome amongst adults in Jordan: prevalence, trend, and its association with socio-demographic characteristics. Diabetol Metab Syndr. 2020;12(1):100. doi:10.1186/s13098-020-00610-7
   PubMed Web of Science ®Google Scholar
• Scarpelli D, Cardellini M, Andreozzi F, et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian Italian subjects. Diabetes. 2006;55(5):1529–1533. doi:10.2337/db06-0047
   PubMed Web of Science ®Google Scholar
• Knowles JW, Xie W, Zhang Z, et al. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest. 2016;126(1):403. doi:10.1172/JCI85921
   PubMed Web of Science ®Google Scholar
• Sim E, Abuhammad A, Ryan A. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. Br J Pharmacol. 2014;171(11):2705–2725. doi:10.1111/bph.12598
   PubMed Web of Science ®Google Scholar
• Srivastava DSL, Aggarwal K, Singh G. Is NAT2 gene polymorphism associated with vitiligo? Indian J Dermatol. 2020;65(3):173–177. doi:10.4103/ijd.IJD_388_18
   PubMed Web of Science ®Google Scholar
• Zhu K, Xu A, Xia W, et al. Association between NAT2 polymorphism and lung cancer risk: a systematic review and meta-analysis. Front Oncol. 2021;11:567762. doi:10.3389/fonc.2021.567762
   PubMed Web of Science ®Google Scholar
• Cui D, Wang Z, Zhao E, Ma J, Lu W. NAT2 polymorphism and lung cancer risk: a meta-analysis. Lung Cancer. 2011;73(2):153–157. doi:10.1016/j.lungcan.2010.12.012
   PubMed Web of Science ®Google Scholar
• Irshaid Y, al-Hadidi H, Abuirjeie M, Latif A, Sartawi O, Rawashdeh N. Acetylator phenotypes of Jordanian diabetics. Eur J Clin Pharmacol. 1992;43(6):621–623. doi:10.1007/BF02284960
   PubMed Web of Science ®Google Scholar
• Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000;9(1):29–42.
   PubMed Web of Science ®Google Scholar
• Ohno M, Yamaguchi I, Yamamoto I, et al. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int J Tuberc Lung Dis. 2000;4(3):256–261.
   PubMed Web of Science ®Google Scholar
• Rego-Perez I, Fernandez-Moreno M, Blanco FJ. Gene polymorphisms and pharmacogenetics in rheumatoid arthritis. Curr Genomics. 2008;9(6):381–393. doi:10.2174/138920208785699553
   PubMed Web of Science ®Google Scholar
• da Silva TD, Felipe AV, De lima JM, Oshima CT, Forones NM. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer. World J Gastroenterol. 2011;17(6):760–765. doi:10.3748/wjg.v17.i6.760
   PubMed Web of Science ®Google Scholar
• Liu C, Cui W, Cong L, et al. Association between NAT2 polymorphisms and lung cancer susceptibility. Medicine. 2015;94(49):e1947. doi:10.1097/MD.0000000000001947
   PubMed Web of Science ®Google Scholar
• Irshaid YM, Abujbara MA, Ajlouni KM, El-Khateeb M, Jarrar YB. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus. Int J Clin Pharmacol Ther. 2013;51(07):593–599. doi:10.5414/CP201883
   PubMedGoogle Scholar
• Al-Shaqha WM, Alkharfy KM, Al-Daghri NM, Mohammed AK. N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population. Ann Saudi Med. 2015;35(3):214–221. doi:10.5144/0256-4947.2015.214
   PubMed Web of Science ®Google Scholar
• Yalin S, Hatungil R, Tamer L, et al. N-acetyltransferase 2 polymorphism in patients with diabetes mellitus. Cell Biochem Funct. 2007;25(4):407–411. doi:10.1002/cbf.1314
   PubMed Web of Science ®Google Scholar
• Jarrar YB, Balasmeh AA, Jarrar W. Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers. Libyan J Med. 2018;13(1):1408381. doi:10.1080/19932820.2017.1408381
   PubMed Web of Science ®Google Scholar
• Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95–104. doi:10.4137/BMI.S38440
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–S69.
   PubMedGoogle Scholar
• Lucena-Aguilar G, Sanchez-Lopez AM, Barberan-Aceituno C, Carrillo-Avila JA, Lopez-Guerrero JA, Aguilar-Quesada R. DNA source selection for downstream applications based on DNA quality indicators analysis. Biopreserv Biobank. 2016;14(4):264–270. doi:10.1089/bio.2015.0064
   PubMed Web of Science ®Google Scholar
• Crossley BM, Bai J, Glaser A, et al. Guidelines for Sanger sequencing and molecular assay monitoring. J Vet Diagn Invest. 2020;32(6):767–775. doi:10.1177/1040638720905833
   PubMed Web of Science ®Google Scholar
• Esteves ARF, Domingues AF, Ferreira IL, et al. Mitochondrial function in Parkinson’s disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 2008;8(3):219–228. doi:10.1016/j.mito.2008.03.004
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265. doi:10.1093/bioinformatics/bth457
   PubMed Web of Science ®Google Scholar
• Liu Z, Lin S. Multilocus LD measure and tagging SNP selection with generalized mutual information. Genet Epidemiol. 2005;29(4):353–364. doi:10.1002/gepi.20092
   PubMed Web of Science ®Google Scholar
• Luca F, Bubba G, Basile M, et al. Multiple advantageous amino acid variants in the NAT2 gene in human populations. PLoS One. 2008;3(9):e3136. doi:10.1371/journal.pone.0003136
   PubMed Web of Science ®Google Scholar
• Totomoch-Serra A, Marquez MF, Cervantes-Barragan DE. Sanger sequencing as a first-line approach for molecular diagnosis of Andersen-Tawil syndrome. F1000Res. 2017;6:1016. doi:10.12688/f1000research.11610.1
   PubMedGoogle Scholar
• Semiz S, Dujic T, Ostanek B, et al. Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina. Arch Med Res. 2011;42(4):311–317. doi:10.1016/j.arcmed.2011.06.007
   PubMed Web of Science ®Google Scholar
• Slatkin M. Linkage disequilibrium--understanding the evolutionary past and mapping the medical future. Nat Rev Genet. 2008;9(6):477–485. doi:10.1038/nrg2361
   PubMed Web of Science ®Google Scholar
• Jarrar YB, Ismail S, Irshaid YM. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers. Int J Clin Pharmacol Ther. 2010;48(10):688–694. doi:10.5414/CPP48688
   PubMed Web of Science ®Google Scholar
• Oqal MK, Mustafa KN, Irshaid YM. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital. Genet Test Mol Biomarkers. 2012;16(9):1007–1010. doi:10.1089/gtmb.2012.0062
   PubMed Web of Science ®Google Scholar
• Zang Y, Doll MA, Zhao S, States JC, Hein DW. Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2. Carcinogenesis. 2007;28(8):1665–1671. doi:10.1093/carcin/bgm085
   PubMed Web of Science ®Google Scholar
• Khamees M, Jarrar Y, Al-Qirim T, et al. No impact of soluble epoxide hydrolase rs4149243, rs2234914 and rs751142 genetic variants on the development of type II diabetes and its hypertensive complication among Jordanian patients. Int J Clin Pract. 2021;75(5):e14036. doi:10.1111/ijcp.14036
   PubMed Web of Science ®Google Scholar
• Hakooz N, Jarrar YB, Zihlif M, Imraish A, Hamed S, Arafat T. Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians. Drug Metab Pers Ther. 2017;32(3):157–162. doi:10.1515/dmpt-2017-0019
   PubMedGoogle Scholar
• McDonagh EM, Boukouvala S, Aklillu E, Hein DW, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics. 2014;24(8):409–425. doi:10.1097/FPC.0000000000000062
   PubMed Web of Science ®Google Scholar
• Howard SG. Developmental exposure to endocrine disrupting chemicals and type 1 diabetes mellitus. Front Endocrinol. 2018;9:513. doi:10.3389/fendo.2018.00513
   PubMed Web of Science ®Google Scholar
• Yan D, Jiao Y, Yan H, Liu T, Yan H, Yuan J. Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Environ Health. 2022;21(1):53. doi:10.1186/s12940-022-00858-8
   PubMed Web of Science ®Google Scholar
• Irshaid YM, al-Hadidi HF, Abuirjeie MA, Rawashdeh NM. N-acetylation phenotyping using dapsone in a Jordanian population. Br J Clin Pharmacol. 1991;32(3):289–293. doi:10.1111/j.1365-2125.1991.tb03901.x
   PubMed Web of Science ®Google Scholar
• Jarrar YB, Al-Essa L, Kilani A, Hasan M, Al-Qerem W. Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice. Diabetes Metab Syndr Obes. 2018;11:483–492. doi:10.2147/DMSO.S172664
   PubMed Web of Science ®Google Scholar
• Iskakova A, Aitkulova A, Sikhayeva N, et al. Dipeptidyl peptidase-4 inhibitors: sensitivity markers. Eurasian J Appl Biotechnol. 2017;24(3):1–7.
   Google Scholar
• Alhawari H, Jarrar Y, Abulebdah D, et al. Effects of vitamin D receptor genotype on lipid profiles and retinopathy risk in type 2 diabetes patients: a pilot study. J Pers Med. 2022;13(1):12. doi:10.3390/jpm13010012
   PubMedGoogle Scholar
• Abdullah S, Jarrar Y, Alhawari H, Abed E, Zihlif M. The Influence of Endothelial Nitric Oxide Synthase (eNOS) genetic polymorphisms on cholesterol blood levels among type 2 diabetic patients on atorvastatin therapy. Endocr Metab Immune Disord Drug Targets. 2021;21(2):352–359. doi:10.2174/1871530320666200621174858
   PubMed Web of Science ®Google Scholar
• Knowles JW, Xie W, Zhang Z, et al. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. J Clin Invest. 2015;125(4):1739–1751. doi:10.1172/JCI74692
   PubMed Web of Science ®Google Scholar